SCOPUS 정보 검색 플랫폼

P and T

Volumn 36, Issue 1, 2011, Pages 33-36

Utilization of methylnaltrexone (relistor) for opioid-induced constipation in an oncology hospital

(6) Watkins, Jack L a Eckmann, Karen R a Mace, Morgan L a Rogers, Jane a Langley, Ginger a Smith, Wendy a

a UNIVERSITY OF TEXAS (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE BROMIDE; LAXATIVE; OPIATE;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; ARTICLE; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG USE; FEMALE; FLATULENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OFF LABEL DRUG USE; PRESCRIPTION;

EID: 78751687451 PISSN: 10521372 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (8)

References (14)

1
- 0036056767
- Opioid antagonists: A review of their role in palliative care, focusing on use in opioid-related constipation
- Choi YS, Billings JA. Opioid antagonists: A review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manage 2002;24:71-90.
- (2002) J Pain Symptom Manage , vol.24 , pp. 71-90
- Choi, Y.S.¹ Billings, J.A.²

2
- 2942567782
- Assessing and managing opiate-induced constipation in adults with cancer
- McMillan SC. Assessing and managing opiate-induced constipation in adults with cancer. Cancer Control 2004;11:3-9.
- (2004) Cancer Control , vol.11 , pp. 3-9
- McMillan, S.C.¹

3
- 34250617568
- Opioid-induced bowel dysfunction: Prevalence, pathophysiology and burden
- Panchal SJ, Müller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: Prevalence, pathophysiology and burden. Int J Clin Pract 2007;61(7):1181-1187.
- (2007) Int J Clin Pract , vol.61 , Issue.7 , pp. 1181-1187
- Panchal, S.J.¹ Müller-Schwefe, P.² Wurzelmann, J.I.³

4
- 78751694099
- FDA June 3, Available at: and www.fda.gov. Accessed June 30, 2010
- FDA. Drug approval package: Relistor (methylnaltrexone bromide) subcutaneous injection. June 3, 2008. Available at: http://tinyurl.com/2uby2uf and www.fda.gov. Accessed June 30, 2010.
- (2008) Drug Approval Package: Relistor (Methylnaltrexone Bromide) Subcutaneous Injection

5
- 44349145194
- Methylnaltrexone for opioid-induced constipation in advanced illness
- Thomas J, Karver S, Cooney GA, et al.Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358(22):2332-2343.
- (2008) N Engl J Med , vol.358 , Issue.22 , pp. 2332-2343
- Thomas, J.¹ Karver, S.² Cooney, G.A.³

6
- 64849097928
- Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients
- Slatkin N, Thomas J, Lipman AG, et al. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol 2009;7(1):39-46.
- (2009) J Support Oncol , vol.7 , Issue.1 , pp. 39-46
- Slatkin, N.¹ Thomas, J.² Lipman, A.G.³

7
- 78751680753
- August 25, Available at: Accessed September 29, 2010
- FDA safety information. Relistor (methylnaltrexone bromide) subcutaneous injections. August 25, 2010. Available at: www.fda.gov/Safety/MedWatch/ SafetyInformation/ucm221639.htm. Accessed September 29, 2010.
- (2010) FDA Safety Information. Relistor (methylnaltrexone bromide) Subcutaneous Injections

8
- 78751697503
- Philadelphia: Wyeth; and Tarrytown, N.Y.: Progenics. Updated May 2010; revised September 2010
- Relistor (methylnaltrexone bromide), prescribing information. Philadelphia: Wyeth; and Tarrytown, N.Y.: Progenics. Updated May 2010; revised September 2010.
- Relistor (Methylnaltrexone Bromide), Prescribing Information

9
- 0018709370
- Effects of radiation on the human gastrointestinal tract
- Novak JM, Collins JT, Donowitz M, et al. Effects of radiation on the human gastrointestinal tract. J Clin Gastroenterol 1979;1(1):9-39.
- (1979) J Clin Gastroenterol , vol.1 , Issue.1 , pp. 9-39
- Novak, J.M.¹ Collins, J.T.² Donowitz, M.³

10
- 71649115884
- How to prevent prescribing errors
- How to prevent prescribing errors. Lancet 2009;374(9706):1945.
- (2009) Lancet , vol.374 , Issue.9706 , pp. 1945

11
- 77956669941
- Alcohol withdrawal: Development of a standing order set
- Riddle E, Bush J, Tittle M, Dilkhush D. Alcohol withdrawal: Development of a standing order set. Crit Care Nurs 2010;30: 38-47.
- (2010) Crit Care Nurs , vol.30 , pp. 38-47
- Riddle, E.¹ Bush, J.² Tittle, M.³ Dilkhush, D.⁴

12
- 45749086591
- Implementation of standard order sets for patient-controlled analgesia
- Weber LM, Ghafoor VL, Phelps P. Implementation of standard order sets for patient-controlled analgesia. Am J Health Syst Pharm 2008;65:1184-1191.
- (2008) Am J Health Syst Pharm , vol.65 , pp. 1184-1191
- Weber, L.M.¹ Ghafoor, V.L.² Phelps, P.³

13
- 62149143664
- Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis
- Thiel SW, Asghar MF, Micek ST, et al. Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis. Crit Care Med 2009;37:819-824.
- (2009) Crit Care Med , vol.37 , pp. 819-824
- Thiel, S.W.¹ Asghar, M.F.² Micek, S.T.³

14
- 61449256105
- Controlling off-label medication use
- Gillick MR. Controlling off-label medication use. Ann Intern Med 2009;150:344-347.
- (2009) Ann Intern Med , vol.150 , pp. 344-347
- Gillick, M.R.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.